Lymphoma
A study to check in DLBCL (a type of lymphoma) patients whose disease disappears with chemotherapy, if Radiation therapy is required for better disease control
Who can joinAdults
Age18+ years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine and radiation
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 18 Aug 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Department of Radiation Oncology, ACTREC, Tata Memorial Centre MumbaiNavi MumbaiDirections ↗
Registry summary (technical)
Role of COnsolidative RADiotherapy in bulky and/or extra-nodal DLBCL (CORAD-DLBCL) with complete metabolic response (CMR) after R-CHOP regimen: A Randomized Controlled Trial - CORAD-DLBCL
Sponsor: Dr Sangeeta Kakoti
CTRI/2024/12/078804 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 18 Aug 2025 · read by us 5 Nov 2026